c-Abl: Activation and nuclear targets

Cell Death and Differentiation

Volumn 7, Issue 1, 2000, Pages 10-16

  Shaul, Y ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Apotosis; Cell cycle; DNA damage; p53; p73; RFX1; Tyrosine kinase activation

Indexed keywords

DNA; ONCOPROTEIN; PROTEIN P53; PROTEIN P73; PROTEIN TYROSINE KINASE;

APOPTOSIS; CELL CYCLE; CELL GROWTH; CELL NUCLEUS; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME STRUCTURE; IONIZING RADIATION; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0034064630     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400626     Document Type: Review

References (75)

1. Van Etten RA (1999) Cycling, stressed-out and nervous: cellular functions of c-Abl. Trends. Cell Biol. 9: 179-186
2. Songyang Z, Shoelson SE, McGlade J et al (1994) Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell Biol. 14: 2777-2785
3. Cohen GB, Ren R and Baltimore D (1995) Modular binding domains in signal transduction proteins. Cell 80: 237-248.
4. Pawson T (1994) SH2 and SH3 domains in signal transduction. Adv. Cancer Res. 64: 87-110
5. Cicchetti P, Mayer BJ, Thiel G and Baltimore D (1992) Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257: 803-806
6. Ren R, Mayer BJ, Cicchetti P and Baltimore D (1993) Identification of a ten-amino acid proline-rich SH3 binding site. Science 259: 1157-1161
7. Shi Y, Alin K and Goff SP (1995) Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes Dev. 9: 2583-2597
8. Dai Z and Pendergast AM (1995) Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes & Dev. 9: 2569-2582
9. Wen ST and Van Etten RA (1997) The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11: 2456-2467
10. Shafman T, Khanna KK, Kedar P et al (1997) Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387: 520-523
11. Baskaran R, Wood LD, Whitaker LL et al (1997) A taxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387: 516-519
12. Kharbanda S, Bharti A, Pei D et al (1996) The stress response to ionizing radiation involves c-Abl-dependent phosphorylation of SHPTP1. Proc. Natl. Acad. Sci. USA 93: 6898-6901
13. Agami R and Shaul Y (1998) The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes. Oncogene 16: 1779-1783
14. Songyang Z, Shoelson SE, Chaudhuri M et al (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72: 767-778
15. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT and Mulligan RC (1991) Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65: 1153-1163
16. Schwatzberg PL, Stall AM, Hardin JD et al (1991) Mice homozygous for the ablm1 mutation show poor viability and depletion of selected B and T cell populations. Cell 65: 1165-1175
17. Kipreos ET and Wang JY (1992) Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 256: 382-385
18. Miao JY and Wang J (1996) Binding of A/T-rich DNA by three high mobility group-like domains in c-Abl tyrosine kinase. J. Biol. Chem. 271: 22823-22830
19. McWhirter JR and Wang JY (19943) An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J. 12: 1533-1546
20. Van Etten R, Jackson PK, Baltimore D, Sanders MC, Matsudaira PT and Janmey PA (1994) The COOH terminus of the c-Abl tyrosine kinase contains distinct F-and G-actin binding domains with bundling activity. J. Cell Biol. 124: 325-340
21. Konopka JB and Witte ON (1985) Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol. Cell Biol. 5: 3116-3123
22. Pendergast AM, Muller AJ, Havlik MH, Clark R, McCormick F and Witte ON (1991) Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. Proc. Natl. Acad. Sci. USA 88: 5927-5931
23. Van Etten R, Jackson P and Baltimore D (1989) The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58: 669-678
24. Mayer BJ and Baltimore D (1994) Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell Biol. 14: 2883-2894
25. Welch PJ and Wang JY (1993) A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75: 779-790
26. Feller SM, Ren R, Hanafusa H and Baltimore D (1994) SH2 and SHS domains as molecular adhesives: the interactions of Crk and Abl. Trends Biochem. Sci. 19: 453-458
27. Xu W, Harrision SC and Eck MJ (1997) Three-dimensiona structure of the tyrosine kinase c-Src. Nature 385: 595-602
28. Sicheri F, Moarefi I and Kuriyan J (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature 385: 602-609
29. Barila D and Superti-Furga G (1998) An intramolecular SH3-domain interaction regulates c-Abl activity. Nat. Genet. 18: 280-282
30. Kharbanda S, Ren R, Pandey P et al (1995) Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376: 785-788
31. Kharbanda S, Pandey P, Jin S et al (1997) Functional interaction between DNA-PK and c-Abl in response to DNA damage. Nature 386: 732-735
32. Nehme A, Baskaran R, Aebi S et al (1997) Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. Cancer Res. 57: 3253-3257
33. Nehme A, Baskaran R, Nebel S et al (1999) Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. Br. J. Cancer 79: 1104-1110
34. David Cordonnier M, Hamdane M, Bailly C and D'Halluin JC (1998) The DNA binding domain of the human c-Abl tyrosine kinase preferentially binds to DNA sequences containing an AAC motif and to distorted DNA structures. Biochemistry 37: 6065-6076
35. Dikstein R, Heffetz D, Ben-Neriah Y and Shaul Y (1992) c-abl has a sequence-specific enhancer binding activity. Cell 69: 751-757
36. Dikstein R, Agami R, Heffetz D and Shaul Y (1996) p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues. Proc. Natl. Acad. Sci. USA 93: 2387-2391
37. Reith W, Ucla C, Barras E et al (1994) RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol. Cell Biol. 14: 1230-1244
38. Dikstein R, Faktor O, Ben-Levy R and Shaul Y (1990) Functional organization of the hepatitis B virus enhancer. Mol. Cell Biol. 10: 3682-3689
39. Goga A, Liu X, Hambuch TM et al (1995) p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11: 791-799
40. Baskaran R, Dahmus ME and Wang JY (1993) Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc. Natl. Acad. Sci. USA 90: 11167-11171
41. Duyster J, Baskaran R and Wang JY (1995) Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain. Proc. Natl. Acad. Sci. USA 92: 1555-1559
42. Welch PJ and Wang JY (1995) Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes & Dev. 9: 31-46
43. Baskaran R, Escobar SR and Wang JY (1999) Nuclear c-Abl is a COOH-terminal repeated domain (CTD)-tyrosine (CTD)-tyrosine kinase-specific for the mammalian RNA polymerase II: possible role in transcription elongation. Cell Growth Differ. 10: 387-396
44. Yuan ZM, Huang Y, Ishiko T et al (1998) Regulation of Rad51 function by c-Abl in response to DNA damage. J. Biol. Chem. 273: 3799-3802
45. Chen G, Yuan SS, Liu W et al (1999) Radiation-induced assembly of rad51 and rad52 recombination complex requires ATM and c-Abl. J. Biol. Chem. 274: 12748-12752
46. Chow CS, Barnes CM and Lippard SJ (1995) A single HMG domain in high mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct. Biochemistry 34: 2956-2964
47. Ohndorf UM, Rould MA, He Q, Pabo CO and Lippard SJ (1999) Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature 399: 708-712
48. Morgan SE and Kastan MB (1997) p53 and ATM: cell cycle, cell death, and cancer. Adv. Cancer Res. 71: 1-25
49. Yuan ZM, Huang Y, Fan MM, Sawyers C, Kharbanda S and Kufe D (1996) Genotoxic drugs induce interaction of the c-Abl tyrosine kinase and the tumor suppressor protein p53. J. Biol. Chem. 271: 26457-26460
50. Yuan ZM, Huang Y, Whang Y et al (1996) Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature 382: 272-274
51. Sawyers CL, McLauglin J, Goga A, Havlik M and Witte O (1994) The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77: 121-131
52. Wen ST, Jackson PK and Van Etten RA (1996) The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J. 15: 1583-1595
53. Daniel R, Cai Y, Wong PM and Chung SW (1995) Deregulation of c-abl mediated cell growth after retroviral transfer and expression of antisense sequences. Oncogene 10: 1607-1614
54. Liu ZG, Baskaran R, Lea-Chou ET et al (1996) Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature 384: 273-276
55. Koleske AJ, Gifford AM, Scott ML et al (1998) Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron. 21: 1259-1272
56. Sionov RV, Moallem E, Berger M et al (1999) c-Abl neutralizes the inhibitory effect of Mdm2 on p53. J. Biol. Chem. 274: 8371-8374
57. Agami R, Blandino G, Oren M and Shaul Y (1999) Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 399: 809-813
58. Yuan ZM, Shioya H, IshikoT et al (1999) p73 is regulated by tyrosine-kinase c-Abl in the apoptotic response to DNA damage [In Process Citation]. Nature 399: 814-817
59. Zhu J, Jiang J, Zhou W and Chen X (1998) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 58: 5061-5065
60. Knudsen ES and Wang JY (1996) Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J. Biol. Chem. 271: 8313-8320
61. Welch PJ and Wang JY (1995) Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Mol. Cell Biol. 15: 5542-5551
62. Friedberg EC, Bardwell AJ, Bardwell L et al (1995) Nucleotide excision repair in the yeast Saccharomyces cerevisiae: its relationship to specialized mitotic recombination and RNA polymerase II basel transcription. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 347: 63-68
63. Elledge SJ, Zhou Z, Allen JB and Navas TA (1993) DNA damage and cell cycle regulation of ribonucleotide reductase. Bioessays 15: 333-339
64. Huang M, Zhou Z and Elledge SJ (1998) The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor. Cell 94: 595-605
65. Katan Y, Agami R and Shaul Y (1997) The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities. Nucleic. Acids Res. 25: 3621-3628
66. Dorsch M and Goff SP (1996) Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines. Proc. Natl. Acad. Sci. USA 23: 13131-13136
67. Yuan ZM, Huang Y, Ishiko T, Kharbanda S, Weichselbaum R and Kufe D (1997) Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 94: 1437-1440
68. Huang Y, Yuan ZM, Ishiko T et al (1997) Pro-apoptotic effect of the c-Abl tyrosine kinase in the cellular response to 1-beta-D-arabinofuranosylcytosine. Oncogene 15: 1947-1952
69. Gong JG, Costanzo A, Yang HQ et al (1999) The tyrosine-kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399: 806-809
70. Dan S, Naito M, Seimiya H, Kizaki A, Mashima T and Tsuruo T (1999) Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/ SAPK activation during apoptosis of human monocytic leukemia U937 cells. Oncogene 18: 1277-1283
71. Kaghad M, Bonnet H, Yang A et al (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819
72. Jost CA, Marin MC and Kaelin WJ (1997) p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191-194
73. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331
74. Venot C, Maratrat M, Dureuil C, Conseiller E, Bracco L and Debussche L (1998) The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J. 17: 4668-4679
75. Schonthal A, Alberts AS, Frost JA and Feramisco JR (1991) Differential regulation of jun family gene expression by the tumor promoter okadaic acid. New Biol. 3: 977-986